Internal medicine is the medical specialty that diagnoses and treats illnesses of the body’s internal systems in adults, such as heart, lung, kidney, digestive and metabolic conditions. Think of internists as general managers of adult health who decide which medicines, tests or specialists are needed; their decisions shape demand for drugs, diagnostics, hospital care and outpatient services, so shifts in internal medicine practice can affect healthcare company revenues and costs.
anesthesiologymedical
Anesthesiology is the medical specialty that manages pain relief, sedation and vital function support during surgery and other procedures, using drugs, monitoring equipment and airway techniques; think of it as the dimmer switch and safety system that keeps patients comfortable and stable while clinicians operate. For investors, anesthesiology matters because innovations, regulatory changes or shifts in drug/device costs, staffing and reimbursement can alter hospital procedure volumes, product sales, profit margins and legal risk, affecting healthcare company revenues and valuations.
microbiology and cell sciencesmedical
An academic and research field that studies microscopic life forms (like bacteria and viruses) and the structure, function and behavior of cells. It explores how these tiny building blocks operate, interact and can be manipulated to make medicines, vaccines, diagnostic tests, agricultural products and industrial processes. Investors care because advances here can create new products, reduce development risk or unlock scalable technologies—similar to improving a factory’s core machinery, which can raise productivity and long-term value.
See more from StockTitan in Google Search and AI answers.Adds StockTitan as a preferred source · opens Google
MINNEAPOLIS & SAN FRANCISCO--(BUSINESS WIRE)--
Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of Patrick McCormack, M.D. as a managing director in the healthcare investment banking group. McCormack will be based in San Francisco and focused on advising biopharma companies on mergers and acquisitions and capital-raising transactions.
“We are excited to welcome Patrick to the healthcare investment banking team. His deep expertise advising biopharma companies across the full spectrum of equity and M&A transactions, combined with his rare scientific and clinical perspective, makes him an exceptional addition to our group. Patrick's extensive relationships with management teams, boards of directors and investors across the sector will further strengthen our ability to deliver outstanding outcomes for our clients,” said Peter Day, global group head of healthcare investment banking at Piper Sandler.
"Piper Sandler has built one of the most respected healthcare investment banking franchises in the industry, and I am excited to join such a talented and driven team. I look forward to leveraging my experience advising biopharma companies to help clients navigate complex transactions and create long-term value," said McCormack.
Prior to joining Piper Sandler, McCormack worked at Wells Fargo Securities, where he served as an executive director in biopharma investment banking. Before Wells Fargo, he held senior roles at Goldman Sachs & Co., SVB Leerink and SunTrust Robinson Humphrey. McCormack also brings a distinguished scientific and clinical background, having earned his doctor of medicine degree from the University of Louisville School of Medicine and completed a residency in internal medicine and anesthesiology. He holds a Master of Business Administration degree from Vanderbilt University and a bachelor’s degree in microbiology and cell sciences from the University of Florida.
ABOUT PIPER SANDLER
Piper Sandler Companies (NYSE: PIPR) is a leading investment bank driven to help clients Realize the Power of Partnership®. Securities brokerage and investment banking services are offered in the U.S. through Piper Sandler & Co., member SIPC and NYSE; in the U.K. through Piper Sandler Ltd., authorized and regulated by the U.K. Financial Conduct Authority; in the EU through Aviditi Capital Advisors Europe GmbH, a tied agent of AHP Capital Management GmbH, authorized and regulated by BaFin; in the Abu Dhabi Global Market through Piper Sandler MENA Ltd., authorized and regulated by the ADGM Financial Services Regulatory Authority. Alternative asset management and fixed income advisory services are offered through separately registered advisory affiliates.
